And studies have shown that SHOX2/RASSF1A methylation exhibits higher sensitivity to small cell lung cancer (SCLC) and squamous cell carcinoma (SCC) than adenocarcinoma.[26]. This evidence concerns the gene RASSF1 and adenocarcinoma.